Lancet neurology
The most recent articles from:
Lancet Neurol
-
Blood biomarkers of neuronal damage could facilitate clinical management of and therapeutic development for Huntington's disease. We investigated whether neurofilament light protein NfL (also known as NF-L) in blood is a potential prognostic marker of neurodegeneration in patients with Huntington's disease. ⋯ Medical Research Council, GlaxoSmithKline, CHDI Foundation, Swedish Research Council, European Research Council, Wallenberg Foundation, and Wolfson Foundation.
-
Biography Historical Article
Henrik Zetterberg: biomarking neurological disorders.
-
Historical Article
Hildegard of Bingen's remedies for Parkinson's disease.